Literature DB >> 6524400

Effects of hyperoxia and hypoxia on dynamic and sustained static performance of the human quadriceps muscle.

O Eiken, P A Tesch.   

Abstract

The influence of variations in inspired PO2 on dynamic and static muscle performance of the left quadriceps muscle was studied. Eight subjects performed (1) 60 maximal consecutive dynamic contractions and (2) one sustained exhaustive static contraction at 27% of maximal voluntary contraction (MVC). Breathing mixtures containing 11%, 21% or 99% O2, were administered. Peak torque as an average of the 60 knee extensions was higher (p less than 0.01) during hyperoxia (mean +/- SE = 104 +/- 4 Nm) than during normoxia (98 +/- 4 Nm), but did not differ significantly between hypoxia (95 +/- 5 Nm) and normoxia. Peak torque of individual extensions declined more rapidly during hypoxia than during normoxia, differing in the final 12 extensions by 11% from normoxic values. Static endurance time was reduced (p less than 0.02) during hypoxia (152 +/- 12 s) as compared to normoxia (189 +/- 13 s) and hyperoxia (169 +/- 11 s). No significant difference in endurance time was demonstrated between hyperoxia and normoxia. Thus, hypoxia impaired muscle performance in both dynamic and sustained static exercise, whereas acute hyperoxia improved dynamic but not static muscle performance. The results are interpreted in terms of differences in rate of intramuscular H+ accumulation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6524400     DOI: 10.1111/j.1748-1716.1984.tb07553.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  10 in total

1.  The increase of duration of isometric contraction may not relate to change of relative oxygenation of forearm muscle.

Authors:  A Usaj
Journal:  Pflugers Arch       Date:  1996       Impact factor: 3.657

Review 2.  The Impact of Hyperoxia on Human Performance and Recovery.

Authors:  Billy Sperlich; Christoph Zinner; Anna Hauser; Hans-Christer Holmberg; Jennifer Wegrzyk
Journal:  Sports Med       Date:  2017-03       Impact factor: 11.136

3.  Muscle endurance and mitochondrial function after chronic normobaric hypoxia: contrast of respiratory and limb muscles.

Authors:  Jorge L Gamboa; Francisco H Andrade
Journal:  Pflugers Arch       Date:  2011-11-24       Impact factor: 3.657

Review 4.  Multiple sprint work : physiological responses, mechanisms of fatigue and the influence of aerobic fitness.

Authors:  Mark Glaister
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

5.  Effects of hypoxia on cerebral and muscle haemodynamics during knee extensions in healthy subjects.

Authors:  Paulo Sergio Chagas Gomes; Cristiane Matsuura; Yagesh N Bhambhani
Journal:  Eur J Appl Physiol       Date:  2012-04-29       Impact factor: 3.078

Review 6.  The Effects of Hyperoxia on Sea-Level Exercise Performance, Training, and Recovery: A Meta-Analysis.

Authors:  Matthew M Mallette; Desmond G Stewart; Stephen S Cheung
Journal:  Sports Med       Date:  2018-01       Impact factor: 11.136

7.  The influence of acute hypoxic exposure on isokinetic muscle force production.

Authors:  Rafael Kenji Ivamoto; Fernanda Patti Nakamoto; Rodrigo Luiz Vancini; Ana Amélia Benedito-Silva; Claudio Andre Barbosa de Lira; Marília Dos Santos Andrade
Journal:  Springerplus       Date:  2014-10-15

8.  Effects of hyperoxia on dynamic muscular endurance are associated with individual whole-body endurance capacity.

Authors:  Yuta Kojima; Chiho Fukusaki; Naokata Ishii
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

9.  Is There a Minimum Effective Dose for Vascular Occlusion During Blood Flow Restriction Training?

Authors:  Arpan Das; Bruce Paton
Journal:  Front Physiol       Date:  2022-04-08       Impact factor: 4.566

Review 10.  Neuromuscular fatigability at high altitude: Lowlanders with acute and chronic exposure, and native highlanders.

Authors:  Luca Ruggiero; Scott W D Harrison; Charles L Rice; Chris J McNeil
Journal:  Acta Physiol (Oxf)       Date:  2022-01-25       Impact factor: 7.523

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.